楊櫻博士擁有國內外醫(yī)藥行業(yè)20年的工作經歷，橫跨業(yè)務發(fā)展、戰(zhàn)略、商業(yè)運營、咨詢、藥物開發(fā)和制造。目前她擔任賽諾菲大中華區(qū)戰(zhàn)略與業(yè)務發(fā)展負責人。在此崗位上，她將致力于推動賽諾菲中國業(yè)務發(fā)展，并為中國戰(zhàn)略的制定及落地做出重要貢獻。
在加入賽諾菲之前，她曾就職于復星醫(yī)藥，擔任高級副總裁兼首席商務官，負責全球業(yè)務和海外業(yè)務拓展。在復星之前，她在輝瑞工作了17年，期間擔任過不同的角色。她曾領導全球團隊制定和執(zhí)行戰(zhàn)略，以推動中長期投資組合、資產組合和組織發(fā)展。
楊櫻博士擁有復旦大學化學學士學位和美國西北大學工業(yè)工程與管理科學博士學位。
Ying has 20 years of pharmaceutical industry experience, immersing in both western and China cultures, and spanning across strategy, business development, business operations, consulting, drug development and manufacturing. She currently leads Sanofi’s Greater China Strategy & Business Development team. In this role, Ying will drive the implementation of the Sanofi China Business Development and be a key contributor to the definition of the China strategy.??
Prior to Sanofi, Ying worked at Fosun Pharmaceuticals as Sr. Vice President, Chief Business and Operations Officer, responsible for global business development and overseas businesses. Before Fosun, she worked in Pfizer for 17 years and served different roles. She was an executive leading global teams and matrix teams to set and execute strategies to drive mid-term to long-term growth, and development of portfolio, assets, and organization.??
Ying holds a Ph.D. in Industrial Engineering & Management Sciences from Northwestern University, and a Bachelor’s degree in Chemistry from Fudan University in Shanghai.